Showing results (1501-1510 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|September 14, 2023
Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatmentWei-Wei Zheng, Hang Zhou, Ping Li, et al.Cancer Immunology, Immunotherapy : CII|September 5, 2023
Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status scoreZhengfeng Zhang, Dazhen Wang, Jianji Zhang, et al.Cancer Immunology, Immunotherapy : CII|August 28, 2023
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE studyMelissa Bersanelli, Alessio Cortellini, Alessandro Leonetti, et al.Cancer Immunology, Immunotherapy : CII|August 29, 2023
Cancer management during the COVID-19 world pandemicNavid Sobhani, Giuseppina Mondani, Giandomenico Roviello, et al.Cancer Immunology, Immunotherapy : CII|August 19, 2023
HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemiaHana Komic, Alexander Hallner, Brwa Ali Hussein, et al.Cancer Immunology, Immunotherapy : CII|August 19, 2023
Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotypeSanshiro Kobayashi, Naoyuki Kondo, Takashi Tomiyama, et al.Cancer Immunology, Immunotherapy : CII|January 17, 2024
Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53Brendan L C Kinney, Sreenivasulu Gunti, Vikash Kansal, et al.Cancer Immunology, Immunotherapy : CII|January 17, 2024
Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastasesCeline Man Ying Li, Yoko Tomita, Bimala Dhakal, et al.Cancer Immunology, Immunotherapy : CII|January 17, 2024
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotypeRussell Towers, Lidia Trombello, Maximilian Fusenig, et al.Cancer Immunology, Immunotherapy : CII|January 17, 2024
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignanciesXinfeng Chen, Binghe Tan, Haizhou Xing, et al.Pageof 651